SCHEMBL123253

SCHEMBL123253

[C]#CCF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL965136 0.67
SCHEMBL8769966 0.59
SCHEMBL5178909 0.59
SCHEMBL721366 0.59
SCHEMBL465037 0.59
SCHEMBL16026432 0.56
SCHEMBL205855 0.56
SCHEMBL9525666 0.56
SCHEMBL715493 0.56
SCHEMBL514082 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 580 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024104061-A1 ELECTROLYTE FOR LITHIUM IRON PHOSPHATE BATTERY, AND LITHIUM IRON PHOSPHATE BATTERY 广州天赐高新材料股份有限公司 2024-05-23 WO claimed
CN-111725563-B Non-aqueous electrolyte of lithium ion battery and lithium ion battery 诺莱特电池材料(苏州)有限公司 2023-09-15 CN claimed
CN-115995606-A Non-aqueous electrolyte of lithium ion battery and lithium ion battery 诺莱特电池材料(苏州)有限公司 2023-04-21 CN claimed
CN-115799631-A Electrolyte for lithium iron phosphate battery and lithium iron phosphate battery 广州天赐高新材料股份有限公司 2023-03-14 CN claimed
CN-110911744-B Lithium ion battery non-aqueous electrolyte and lithium ion battery 深圳新宙邦科技股份有限公司 2021-09-17 CN claimed
CN-112574269-A Purine nucleoside compound and application thereof 中国科学院上海药物研究所 2021-03-30 CN claimed
CN-111725563-A Lithium ion battery non-aqueous electrolyte and lithium ion battery 诺莱特电池材料(苏州)有限公司 2020-09-29 CN claimed
CN-110911744-A Lithium ion battery non-aqueous electrolyte and lithium ion battery 深圳新宙邦科技股份有限公司 2020-03-24 CN claimed
US-10301280-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2019-05-28 US claimed
US-10081601-B2 Glucocerebrosidase modulators and uses thereof ALECTOS THERAPEUTICS INC. (CA) 2018-09-25 US claimed
US-9676748-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2017-06-13 US claimed
US-20170029379-A1 GLUCOCEREBROSIDASE MODULATORS AND USES THEREOF ALECTOS THERAPEUTICS INC. (CA) 2017-02-02 US claimed
EP-3087056-A1 GLUCOCEREBROSIDASE MODULATORS AND USES THEREOF Alectos Therapeutics Inc. (CA) 2016-11-02 EP claimed
EP-2935248-A2 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR Plexxikon, Inc. (US) 2015-10-28 EP claimed
WO-2015095963-A1 GLUCOCEREBROSIDASE MODULATORS AND USES THEREOF ALECTOS THERAPEUTICS INC. (CA) 2015-07-02 WO claimed
US-20140213554-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC. 2014-07-31 US claimed
WO-2014100620-A2 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC. (US) 2014-06-26 WO claimed
US-8710084-B2 Tetrazolyl oxime derivative, salt thereof, and plant disease control agent NIPPON SODA CO., LTD. (JP) 2014-04-29 US claimed
US-20090042957-A1 Substituted Oxyarenes BAYER CROPSCIENCE AG (DE) 2009-02-12 US claimed
WO-1995032261-A1 FLUOROALKYL ETHINYL AND DIFLUOROALKYL ETHINYL BENZENES AND THEIR USE IN LIQUID CRYSTAL MIXTURES MERCK PATENT GMBH (DE) 1995-11-30 WO claimed